UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bacterial ratchet motors

Proceedings of the National Academy of Sciences - PNAS, 2010-05, Vol.107 (21), p.9541-9545

2010

Volltextzugriff (PDF)

Swimming with an image

Physical review letters, 2011-01, Vol.106 (3), p.038101-038101, Article 038101

2011

Volltextzugriff (PDF)

OC.06.3 PROTECTIVE ACTIVITY OF LACTOBACILLUS RHAMNOSUS GG-DERIVED FACTORS ON PATHOGEN LIPOPOLYSACCHARIDE (LPS)-INDUCED DAMAGE OF HUMAN COLONIC SMOOTH MUSCLE CELLS

Digestive and liver disease, 2016-02, Vol.48, p.e91-e92

2016

Volltextzugriff (PDF)

Gut Microbiota and the Immune System: An Intimate Partnership in Health and Disease

International journal of immunopathology and pharmacology, 2012-10, Vol.25 (4), p.823-833

2012

Volltextzugriff (PDF)

Influence of oral conditions on colonization by highly toxigenic Staphylococcus aureus strains

Oral diseases, 2012-05, Vol.18 (4), p.402-409

2012

Volltextzugriff (PDF)

P41 DOES THE GUT MICROBIOTA MODULATE THE INFLAMMATORY STATE IN CIRRHOTIC HOST?

Journal of hepatology, 2014-04, Vol.60 (1), p.S80-S80

2014

Volltextzugriff (PDF)

Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance

European journal of clinical microbiology & infectious diseases, 2012-08, Vol.31 (8), p.1917-1921

2012

Volltextzugriff (PDF)

OP‐3 THE PROTECTIVE ROLE OF LACTOBACILLUS RHAMNOSUS GG‐DERIVED FACTORS AGAINST LPS‐INDUCED DAMAGE OF HUMAN COLONIC SMOOTH MUSCLE CELLS

Journal of pediatric gastroenterology and nutrition, 2015-10, Vol.61 (4), p.509-510

2015

Volltextzugriff (PDF)

Microbiological and molecular characterization of nosocomial and community Staphylococcus aureus isolates

Epidemiology and infection, 2011-04, Vol.139 (4), p.613-622

2011

Volltextzugriff (PDF)

Does the gut microbiota modulate the inflammatory state in cirrhotic host?

Digestive and liver disease, 2014-02, Vol.46, p.e34-e34

2014

Volltextzugriff (PDF)

Diffusion of meticillin-resistant Staphylococcus aureus USA300 strains in central Italy

International journal of antimicrobial agents, 2011-04, Vol.37 (4), p.339-346

2011

Volltextzugriff (PDF)

117 Achromobacter xylosoxidans characteristics important for lung colonization of cystic fibrosis (CF) patients

Journal of cystic fibrosis, 2013-06, Vol.12, p.S78-S78

2013

Volltextzugriff (PDF)

Multifaceted modes of action of the anticancer probiotic Enterococcus hirae

Cell death and differentiation, 2021-07, Vol.28 (7), p.2276-2295

2021

Volltextzugriff (PDF)

Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis

Cancer discovery, 2022-04, Vol.12 (4), p.1128-1151

2022

Volltextzugriff (PDF)

PO36 CHARACTERIZATION OF MUCOSA-ASSOCIATED AND FECAL MICROBIOTA OF CHILDREN WITH AUSTISM SPECTRUM DISORDER

Digestive and liver disease, 2012-10, Vol.44, p.S273-S274

2012

Volltextzugriff (PDF)

WS3.3 Molecular characterization of fecal microbiota and metabolic profiles association in cystic fibrosis patients

Journal of cystic fibrosis, 2013-06, Vol.12, p.S5-S5

2013

Volltextzugriff (PDF)

WS8.3 Cystic fibrosis transmembrane conductance regulator ( CFTR ) allelic variants relate to shifts in fecal microbiota of cystic fibrosis patients

Journal of cystic fibrosis, 2013-06, Vol.12, p.S16-S16

2013

Volltextzugriff (PDF)

1452MO Longitudinal analysis reveals gut microbiota shift during standard therapies in metastatic renal cell carcinoma (mRCC)

Annals of oncology, 2022-09, Vol.33, p.S1208

2022

Volltextzugriff (PDF)

259MO A predictive score of cancer immunotherapy responses based on ecological analysis of gut microbiota

Annals of oncology, 2022-11, Vol.33, p.S1534-S1534

2022

Volltextzugriff (PDF)

JC Viral Reactivation in a Pediatric Patient with Crohn's Disease

International journal of immunopathology and pharmacology, 2010-07, Vol.23 (3), p.955-959

2010

Volltextzugriff (PDF)

974P - Prior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota ‘guilds’ in renal cell carcinoma (RCC) patients

Annals of oncology, 2019-10, Vol.30, p.v395-v395

2019

Volltextzugriff (PDF)

Prior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota ‘guilds’ in renal cell carcinoma (RCC) patients

Annals of oncology, 2019-10, Vol.30, p.v395

2019

Volltextzugriff (PDF)

974PPrior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota ‘guilds’ in renal cell carcinoma (RCC) patients

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

A functional metagenomics investigation of cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy

Journal of hepatology, 2018-04, Vol.68, p.S606

2018

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(34)
Berichte
(1)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Humans
(9)
Female
(6)
Gastroenterology And Hepatology
(6)
Antibiotics
(5)
Infectious Diseases
(5)
Microbiology
(5)
Immunology
(4)
Life Sciences
(4)
Male
(4)
Pharmacology & Pharmacy
(4)
Staphylococcus Aureus
(4)
Adult
(3)
Anti-Bacterial Agents - Pharmacology
(3)
Bacteriology
(3)
Biological And Medical Sciences
(3)
Escherichia Coli
(3)
Medicin Och Hälsovetenskap
(3)
Microbiology And Parasitology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bacterial ratchet motors

Swimming with an image

OC.06.3 PROTECTIVE ACTIVITY OF LACTOBACILLUS RHAMNOSUS GG-DERIVED FACTORS ON PATHOGEN LIPOPOLYSACCHARIDE (LPS)-INDUCED DAMAGE OF HUMAN COLONIC SMOOTH MUSCLE CELLS

Gut Microbiota and the Immune System: An Intimate Partnership in Health and Disease

Influence of oral conditions on colonization by highly toxigenic Staphylococcus aureus strains

Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

P41 DOES THE GUT MICROBIOTA MODULATE THE INFLAMMATORY STATE IN CIRRHOTIC HOST?

Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance

OP‐3 THE PROTECTIVE ROLE OF LACTOBACILLUS RHAMNOSUS GG‐DERIVED FACTORS AGAINST LPS‐INDUCED DAMAGE OF HUMAN COLONIC SMOOTH MUSCLE CELLS

Microbiological and molecular characterization of nosocomial and community Staphylococcus aureus isolates

Does the gut microbiota modulate the inflammatory state in cirrhotic host?

Diffusion of meticillin-resistant Staphylococcus aureus USA300 strains in central Italy

117 Achromobacter xylosoxidans characteristics important for lung colonization of cystic fibrosis (CF) patients

Multifaceted modes of action of the anticancer probiotic Enterococcus hirae

Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis

PO36 CHARACTERIZATION OF MUCOSA-ASSOCIATED AND FECAL MICROBIOTA OF CHILDREN WITH AUSTISM SPECTRUM DISORDER

WS3.3 Molecular characterization of fecal microbiota and metabolic profiles association in cystic fibrosis patients

WS8.3 Cystic fibrosis transmembrane conductance regulator ( CFTR ) allelic variants relate to shifts in fecal microbiota of cystic fibrosis patients

1452MO Longitudinal analysis reveals gut microbiota shift during standard therapies in metastatic renal cell carcinoma (mRCC)

259MO A predictive score of cancer immunotherapy responses based on ecological analysis of gut microbiota

JC Viral Reactivation in a Pediatric Patient with Crohn's Disease

974P - Prior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota ‘guilds’ in renal cell carcinoma (RCC) patients

Prior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota ‘guilds’ in renal cell carcinoma (RCC) patients

974PPrior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota ‘guilds’ in renal cell carcinoma (RCC) patients

A functional metagenomics investigation of cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy

Suchergebnisse filtern